Back to Search Start Over

Novel nano-in-micro fabrication technique of diclofenac nanoparticles loaded microneedle patches for localised and systemic drug delivery.

Authors :
Li M
Vora LK
Peng K
Sabri AHB
Qin N
Abbate M
Paredes AJ
McCarthy HO
Donnelly RF
Source :
Biomaterials advances [Biomater Adv] 2024 Jul; Vol. 161, pp. 213889. Date of Electronic Publication: 2024 May 09.
Publication Year :
2024

Abstract

Diclofenac, a nonsteroidal anti-inflammatory drug, is commonly prescribed for managing osteoarthritis, rheumatoid arthritis, and post-surgical pain. However, oral administration of diclofenac often leads to adverse effects. This study introduces an innovative nano-in-micro approach to create diclofenac nanoparticle-loaded microneedle patches aimed at localised, sustained pain relief, circumventing the drawbacks of oral delivery. The nanoparticles were produced via wet-milling, achieving an average size of 200 nm, and then incorporated into microneedle patches. These patches showed improved skin penetration in ex vivo tests using Franz-cell setups compared to traditional diclofenac formulations. In vivo tests on rats revealed that the nanoparticle-loaded microneedle patches allowed for quick drug uptake and prolonged release, maintaining drug levels in tissues for up to 72 h. With a systemic bioavailability of 57 %, these patches prove to be an effective means of transdermal drug delivery. This study highlights the potential of this novel microneedle delivery system in enhancing the treatment of chronic pain with reduced systemic side effects.<br />Competing Interests: Declaration of competing interest Ryan Donnelly is an inventor of patents that have been licenced to companies developing microneedle-based products and is a paid advisor to companies developing microneedle-based products. The resulting potential conflict of interest has been disclosed and is managed by Queen's University Belfast. The companies had no role in the design of the present studies, in the collection, analyses or interpretation of the data, in the writing of the manuscript or in the decision to publish the work. Other all authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
2772-9508
Volume :
161
Database :
MEDLINE
Journal :
Biomaterials advances
Publication Type :
Academic Journal
Accession number :
38781739
Full Text :
https://doi.org/10.1016/j.bioadv.2024.213889